- Home
- TPST vs VVOS Comparison
TPST vs VVOS Comparison
Compare TPST & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- VVOS
- Stock Information
- Founded
- TPST 2011
- VVOS 2016
- Country
- TPST United States
- VVOS United States
- Employees
- TPST N/A
- VVOS N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- VVOS Medical Specialities
- Sector
- TPST Health Care
- VVOS Health Care
- Exchange
- TPST Nasdaq
- VVOS Nasdaq
- Market Cap
- TPST 33.0M
- VVOS 27.3M
- IPO Year
- TPST N/A
- VVOS 2020
- Fundamental
- Price
- TPST $10.16
- VVOS $4.45
- Analyst Decision
- TPST Hold
- VVOS Strong Buy
- Analyst Count
- TPST 3
- VVOS 2
- Target Price
- TPST $30.00
- VVOS $6.10
- AVG Volume (30 Days)
- TPST 111.5K
- VVOS 164.4K
- Earning Date
- TPST 08-11-2025
- VVOS 08-26-2025
- Dividend Yield
- TPST N/A
- VVOS N/A
- EPS Growth
- TPST N/A
- VVOS N/A
- EPS
- TPST N/A
- VVOS N/A
- Revenue
- TPST N/A
- VVOS $14,628,000.00
- Revenue This Year
- TPST N/A
- VVOS $3.83
- Revenue Next Year
- TPST N/A
- VVOS $25.27
- P/E Ratio
- TPST N/A
- VVOS N/A
- Revenue Growth
- TPST N/A
- VVOS 9.47
- 52 Week Low
- TPST $5.35
- VVOS $1.98
- 52 Week High
- TPST $20.67
- VVOS $7.95
- Technical
- Relative Strength Index (RSI)
- TPST 72.60
- VVOS 46.84
- Support Level
- TPST $6.96
- VVOS $3.72
- Resistance Level
- TPST $10.90
- VVOS $4.81
- Average True Range (ATR)
- TPST 0.63
- VVOS 0.51
- MACD
- TPST 0.33
- VVOS -0.10
- Stochastic Oscillator
- TPST 81.24
- VVOS 36.96
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.